Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ALEMBIC ZYDUS LIFESCIENCES/
ALEMBIC
 
P/E (TTM) x 33.4 27.0 123.5% View Chart
P/BV x 5.6 1.0 567.4% View Chart
Dividend Yield % 0.6 2.7 22.5%  

Financials

 ZYDUS LIFESCIENCES   ALEMBIC
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
ALEMBIC
Mar-23
ZYDUS LIFESCIENCES/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs49587 568.9%   
Low Rs31956 575.3%   
Sales per share (Unadj.) Rs170.35.0 3,436.7%  
Earnings per share (Unadj.) Rs19.83.1 629.9%  
Cash flow per share (Unadj.) Rs26.93.4 791.4%  
Dividends per share (Unadj.) Rs6.002.20 272.7%  
Avg Dividend yield %1.53.1 47.7%  
Book value per share (Unadj.) Rs173.080.9 213.8%  
Shares outstanding (eoy) m1,012.20256.78 394.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.414.4 16.6%   
Avg P/E ratio x20.622.7 90.7%  
P/CF ratio (eoy) x15.121.0 72.2%  
Price / Book Value ratio x2.40.9 267.2%  
Dividend payout %30.370.1 43.3%   
Avg Mkt Cap Rs m412,14418,298 2,252.4%   
No. of employees `000NANA-   
Total wages/salary Rs m24,564240 10,216.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,3741,272 13,546.9%  
Other income Rs m4,746643 738.5%   
Total revenues Rs m177,1201,915 9,248.8%   
Gross profit Rs m29,677297 9,984.2%  
Depreciation Rs m7,22767 10,749.7%   
Interest Rs m1,2995 27,935.5%   
Profit before tax Rs m25,897868 2,983.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,87862 9,512.9%   
Profit after tax Rs m20,019806 2,483.2%  
Gross profit margin %17.223.4 73.7%  
Effective tax rate %22.77.1 318.8%   
Net profit margin %11.663.4 18.3%  
BALANCE SHEET DATA
Current assets Rs m100,0821,721 5,814.2%   
Current liabilities Rs m55,267838 6,594.2%   
Net working cap to sales %26.069.4 37.5%  
Current ratio x1.82.1 88.2%  
Inventory Days Days505,038 1.0%  
Debtors Days Days94673 13.9%  
Net fixed assets Rs m144,77620,324 712.3%   
Share capital Rs m1,012514 197.1%   
"Free" reserves Rs m174,14620,267 859.3%   
Net worth Rs m175,15820,780 842.9%   
Long term debt Rs m00-   
Total assets Rs m244,94022,046 1,111.0%  
Interest coverage x20.9187.7 11.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.1 1,219.3%   
Return on assets %8.73.7 236.6%  
Return on equity %11.43.9 294.6%  
Return on capital %15.54.2 369.7%  
Exports to sales %39.21.2 3,180.9%   
Imports to sales %11.92.4 507.1%   
Exports (fob) Rs m67,57716 430,975.8%   
Imports (cif) Rs m20,54430 68,709.0%   
Fx inflow Rs m67,57716 430,975.8%   
Fx outflow Rs m20,54430 68,709.0%   
Net fx Rs m47,033-14 -330,752.5%   
CASH FLOW
From Operations Rs m26,888389 6,920.4%  
From Investments Rs m11,71273 16,052.6%  
From Financial Activity Rs m-44,004-464 9,486.1%  
Net Cashflow Rs m-5,338-2 222,416.7%  

Share Holding

Indian Promoters % 75.0 70.9 105.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 0.9 1,918.1%  
FIIs % 5.0 0.9 560.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 29.1 85.9%  
Shareholders   306,495 94,012 326.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs ALEMBIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs ALEMBIC Share Price Performance

Period Cadila Healthcare ALEMBIC S&P BSE HEALTHCARE
1-Day -1.70% -1.08% -1.25%
1-Month 7.26% -21.70% -5.29%
1-Year 104.62% 31.56% 57.01%
3-Year CAGR 31.78% -7.21% 18.03%
5-Year CAGR 23.62% 12.95% 18.81%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the ALEMBIC share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of ALEMBIC the stake stands at 70.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of ALEMBIC.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

ALEMBIC paid Rs 2.2, and its dividend payout ratio stood at 70.1%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of ALEMBIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.